NEW YORK (GenomeWeb News) – Fitch Ratings today downgraded its long-term issuer default rating on Thermo Fisher Scientific to 'BBB' from 'BBB+' and assigned a 'BBB' rating to Thermo Fisher's proposed senior notes, which have yet to be priced.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.
Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.
Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.
A new report indicates that women are underrepresented among US patent holders.